Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Frontiers in Immunology|September 29, 2023
The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapyApoorvi Chaudhri, Xia Bu, Yunfei Wang, et al.The Journal of Experimental Medicine|April 23, 2014
RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory toleranceYanping Xiao, Sanhong Yu, Baogong Zhu, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 20, 2010
T cell/transmembrane, Ig, and mucin-3 allelic variants differentially recognize phosphatidylserine and mediate phagocytosis of apoptotic cellsRosemarie H DeKruyff, Xia Bu, Angela Ballesteros, et al.Nature Medicine|August 22, 2018
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy responsePeng Jiang, Shengqing Gu, Deng Pan, et al.Journal for Immunotherapy of Cancer|January 14, 2026
CD47 destabilization via manipulating the SPOP-USP2 axis augments macrophage phagocytosis and cancer immunotherapyPeiqiang Yan, Xia Bu, Tao Hou, et al.Molecular Cell|April 28, 2021
Energy status dictates PD-L1 protein abundance and anti-tumor immunity to enable checkpoint blockadeXiaoming Dai, Xia Bu, Yang Gao, et al.Nature|November 22, 2017
Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillanceJinfang Zhang, Xia Bu, Haizhen Wang, et al.Cancer Immunology Research|October 12, 2021
Monitoring PD-1 Phosphorylation to Evaluate PD-1 Signaling during Antitumor Immune ResponsesXia Bu, Vikram R Juneja, Carol G Reynolds, et al.Nature|July 5, 2019
Author Correction: Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillanceJinfang Zhang, Xia Bu, Haizhen Wang, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 5, 2010
Apoptotic cells activate NKT cells through T cell Ig-like mucin-like-1 resulting in airway hyperreactivityHyun-Hee Lee, Everett H Meyer, Sho Goya, et al.Pageof 4